Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole

Table 1 Characteristics of study participants

Subject	CYP2C19	Age	Height (cm)	Body weight (kg)	BMI
1	Homo-EM	23	171	70	23.9
2	Homo-EM	26	170	58	20.1
3	Homo-EM	28	169	60	21.0
4	Hetero-EM	22	165	60	22.0
5	Hetero-EM	28	170	80	27.6
6	Hetero-EM	40	172	75	25.3
7	Hetero-EM	44	181	82	25.0
8	PM	23	172	60	20.2
9	PM	23	175	55	18.0
10	PM	30	174	86	28.4

Homo-EM: Homo-extensive metabolizer; Hetero-EM: Hetero-extensive metabolizer; PM: Poor metabolizer.